Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner bought 39,500,000 shares of Percheron Therapeutics stock in a transaction dated Wednesday, February 26th. The shares were bought at an average cost of A$0.01 ($0.01) per share, for a total transaction of A$474,000.00 ($300,000.00).
James Garner also recently made the following trade(s):
- On Tuesday, December 24th, James Garner purchased 1,500,000 shares of Percheron Therapeutics stock. The shares were purchased at an average price of A$0.01 ($0.00) per share, for a total transaction of A$10,500.00 ($6,645.57).
Percheron Therapeutics Stock Performance
About Percheron Therapeutics
Read More
- Five stocks we like better than Percheron Therapeutics
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- The 3 Best Retail Stocks to Shop for in August
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
- What is the MACD Indicator and How to Use it in Your Trading
- Will Alibaba’s $53B AI Bet Be the Key to Tech Supremacy?
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
